These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 10751058

  • 1. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
    Katafuchi R, Saito S, Ikeda K, Hirano T, Yanase T, Nakashima K, Fujimi S.
    Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
    [Abstract] [Full Text] [Related]

  • 2. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
    Wiener Y, Nakhleh RE, Lee MW, Escobar FS, Venkat KK, Kupin WL, Mozes MF.
    Clin Transplant; 1997 Jun; 11(3):157-62. PubMed ID: 9193835
    [Abstract] [Full Text] [Related]

  • 3. Tacrolimus-associated hemolytic uremic syndrome: a case analysis.
    Lin CC, King KL, Chao YW, Yang AH, Chang CF, Yang WC.
    J Nephrol; 2003 Jun; 16(4):580-5. PubMed ID: 14696762
    [Abstract] [Full Text] [Related]

  • 4. Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy.
    Bren A, Pajek J, Grego K, Buturovic J, Ponikvar R, Lindic J, Knap B, Vizjak A, Ferluga D, Kandus A.
    Transplant Proc; 2005 May; 37(4):1889-91. PubMed ID: 15919494
    [Abstract] [Full Text] [Related]

  • 5. Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections.
    Artz MA, Steenbergen EJ, Hoitsma AJ, Monnens LA, Wetzels JF.
    Transplantation; 2003 Sep 15; 76(5):821-6. PubMed ID: 14501861
    [Abstract] [Full Text] [Related]

  • 6. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients.
    Paydaş S, Balal M, Sertdemir Y, Seyrek N, Karayaylali I.
    Ren Fail; 2005 Sep 15; 27(4):409-13. PubMed ID: 16060128
    [Abstract] [Full Text] [Related]

  • 7. Combination of everolimus with calcineurin inhibitor medication resulted in post-transplant haemolytic uraemic syndrome in lung transplant recipients--a case series.
    Lovric S, Kielstein JT, Kayser D, Bröcker V, Becker JU, Hiss M, Schiffer M, Sommerwerck U, Haller H, Strüber M, Welte T, Gottlieb J.
    Nephrol Dial Transplant; 2011 Sep 15; 26(9):3032-8. PubMed ID: 21310739
    [Abstract] [Full Text] [Related]

  • 8. Shiga toxin-associated hemolytic uremic syndrome: absence of recurrence after renal transplantation.
    Ferraris JR, Ramirez JA, Ruiz S, Caletti MG, Vallejo G, Piantanida JJ, Araujo JL, Sojo ET.
    Pediatr Nephrol; 2002 Oct 15; 17(10):809-14. PubMed ID: 12376808
    [Abstract] [Full Text] [Related]

  • 9. [A case of subclinical IgA nephropathy and cyclosporin associated arteriolopathy diagnosed by non-episode biopsy of graft kidney after renal transplantation].
    Namba Y, Kyakuno M, Nakamura T, Yamashiro H, Okada M, Toki K, Ichimaru N, Kokado Y, Takahara S, Okuyama A, Oka K, Imai E, Kyo M.
    Hinyokika Kiyo; 1999 May 15; 45(5):349-53. PubMed ID: 10410319
    [Abstract] [Full Text] [Related]

  • 10. Posttransplantation calcineurin inhibitor-induced hemolytic uremic syndrome: single-center experience.
    Said T, Al-Otaibi T, Al-Wahaib S, Francis I, Nair MP, Halim MA, El-Sayed A, Nampoory MR.
    Transplant Proc; 2010 Apr 15; 42(3):814-6. PubMed ID: 20430179
    [Abstract] [Full Text] [Related]

  • 11. The Bergamo Kidney Transplant Program.
    Perico N, Cravedi P, Ruggenenti P, Gotti E, Rota G, Locatelli G, Gambara V, Perna A, Rota S, Remuzzi G.
    Clin Transpl; 2005 Apr 15; ():85-100. PubMed ID: 17424727
    [Abstract] [Full Text] [Related]

  • 12. Graft failure due to hemolytic uremic syndrome recurrence.
    Iaria G, Iorio B, Anselmo A, De Luca L, Tariciotti L, Ielpo B, Muzi F, Lucchesi C, D'Andria D, Orlando G, Del Poeta G, Poggi E, Piazza A, Tisone G.
    Transplant Proc; 2006 May 15; 38(4):1020-1. PubMed ID: 16757250
    [Abstract] [Full Text] [Related]

  • 13. [Hemolytic-uremic syndrome following kidney transplantation: prognostic factors].
    Candinas D, Keusch G, Schlumpf R, Burger HR, Gmür J, Largiadèr F.
    Schweiz Med Wochenschr; 1994 Oct 15; 124(41):1789-99. PubMed ID: 7973505
    [Abstract] [Full Text] [Related]

  • 14. The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors.
    Fukuhara N, Ono Y, Hattori R, Nishiyama N, Yamada S, Kamihira O, Kinukawa T, Ohshima S.
    Clin Transplant; 2005 Apr 15; 19(2):153-7. PubMed ID: 15740548
    [Abstract] [Full Text] [Related]

  • 15. Renal transplantation in 20 children with hemolytic-uremic syndrome.
    Eijgenraam FJ, Donckerwolcke RA, Monnens LA, Proesmans W, Wolff ED, van Damme B.
    Clin Nephrol; 1990 Feb 15; 33(2):87-93. PubMed ID: 2311309
    [Abstract] [Full Text] [Related]

  • 16. De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine.
    Van Buren D, Van Buren CT, Flechner SM, Maddox AM, Verani R, Kahan BD.
    Surgery; 1985 Jul 15; 98(1):54-62. PubMed ID: 3892747
    [Abstract] [Full Text] [Related]

  • 17. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
    Furlong T, Storb R, Anasetti C, Appelbaum FR, Deeg HJ, Doney K, Martin P, Sullivan K, Witherspoon R, Nash RA.
    Bone Marrow Transplant; 2000 Nov 15; 26(9):985-91. PubMed ID: 11100278
    [Abstract] [Full Text] [Related]

  • 18. Immunosuppression in live-related donor renal transplantation.
    Iman A, Rao M, Juneja R, Jacob CK.
    Natl Med J India; 2001 Nov 15; 14(2):75-80. PubMed ID: 11396322
    [Abstract] [Full Text] [Related]

  • 19. [A case of hemolytic uremic syndrome after cadaveric renal transplantation].
    Nagano T, Ikegami M, Matsuda H, Akiyama T, Kurita T.
    Hinyokika Kiyo; 1996 Jan 15; 42(1):59-61. PubMed ID: 8686587
    [Abstract] [Full Text] [Related]

  • 20. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan 15; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.